SOURCE: OmniComm Systems, Inc.

August 05, 2008 12:26 ET

Colorado Prevention Center Adopts Electronic Data Capture and Chooses OmniComm Systems, Inc. as Its Premier Vendor

Academic Research Organization Becomes an OmniComm CRO Preferred Program™ Partner

FT. LAUDERDALE, FL--(Marketwire - August 5, 2008) - OmniComm Systems, Inc. (OTCBB: OMCM), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that Colorado Prevention Center (CPC) has chosen OmniComm as their preferred provider as they move from paper data collection to EDC for their clinical trials. CPC delivers all of the traditional services of a CRO with additional emphasis on the quality of the science and trial conduction. Joining the CRO Preferred Program allows them to offer superior electronic data capture services and support to their clinical development clients worldwide.

"We conducted an exhaustive search of EDC vendors that drilled down to 30 high level candidates. Ten (10) of those companies were issued a request for proposal and only 4 leading companies were chosen to provide demonstrations of their products and services. OmniComm exceeded our expectations with the best services and software by far and was the clear winner in the evaluation," said Evan King, COO of Colorado Prevention Center. "We are very excited to have made the move to EDC and we look forward to working in tandem with the team at OmniComm."

CPC (www.cpcmed.org) is dedicated to improving health through clinical research and integrating scientific evidence into community prevention programs. CPC supports every aspect of clinical research, including study design, comprehensive trial management and completion of final study reports. In addition to these traditional services, CPC provides a unique quality intervention program that improves the ability to detect treatment effect. CPC also provides unmatched scientific leadership and publications of academic hypotheses arising from industry and non-industry research.

"When companies like CPC join our CRO Preferred Program, they gain an EDC partner that shares their dedication to delivering excellence," said Stephen Johnson, COO of OmniComm. "In this highly competitive marketplace, CROs need to know that they have a real partner that they can trust to provide the same high caliber deliverables that their clients have come to expect. Working with OmniComm ensures that level of security for our partners that choose to use TrialMaster™ for EDC."

About OmniComm

OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices in Bonn, Germany, Tula, Russia, California, Maryland, New York, North Carolina and Texas.

Safe Harbor Disclaimer

Statements about OmniComm's future expectations, including without limitation, future revenues and earnings, plans and objectives for the future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. OmniComm intends that such forward-looking statements be subject to the Safe Harbors created thereby. Since these statements involve risks and uncertainties, including but not limited to economic competitive, governmental, contractual and technological factors affecting OmniComm's operations, markets and profitability, actual results could differ materially and adversely from the expected results.

Contact Information

  • CONTACT:
    Lizanne Kelley
    OmniComm Systems, Inc.
    954-473-1254 Extension 283
    Email Contact

    Evan King
    CPC
    789 Sherman St., Suite 200
    Denver, CO 80203
    303.860.9900
    Email Contact